Tg Therapeutics (TGTX) Tax Provisions (2012 - 2026)

Tg Therapeutics' Tax Provisions history runs 5 years deep, the most recent figure standing at $586000.0 for Q1 2026.

• In Q1 2026, Tax Provisions rose 46.5% year-over-year to $586000.0; the TTM figure through Mar 2026 stood at -$339.6 million (down 13113.18% YoY), while the FY2025 annual figure was -$339.8 million, down 15468.11% from the prior year.
• Tax Provisions was $586000.0 for Q1 2026 at Tg Therapeutics, down from $22.1 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $22.1 million in Q4 2025 to a low of -$365.0 million in Q3 2025.
• Historically, Tax Provisions has averaged -$33.7 million across 4 years, with a median of $395000.0 in 2023.
• Biggest YoY gain for Tax Provisions was 1279.31% in 2025; the steepest drop was 94168.56% in 2025.
• A 4-year view of Tax Provisions shows it stood at $390000.0 in 2023, then surged by 444.1% to $2.1 million in 2024, then jumped by 939.4% to $22.1 million in 2025, then plunged by 97.34% to $586000.0 in 2026.
• The last three Tax Provisions figures came in at $586000.0 (Q1 2026), $22.1 million (Q4 2025), and -$365.0 million (Q3 2025), per Business Quant data.